Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-06-21
2011-06-21
Helms, Larry R (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S192100, C435S069700
Reexamination Certificate
active
07964200
ABSTRACT:
The present invention relates, in part, to methods and compositions for immunizing against infection byChlamydia trachomatis. The methods and compositions rely, in part, on administering an immunogenic composition comprising one or more peptides derived fromC. trachomatismajor outer membrane protein (MOMP) to a subject to be immunized. In some embodiments, the compositions comprise a chimeric immunogen comprising a receptor binding domain, a translocation domain, and aChlamydia trachomatisantigen. Polynucleotides encoding the chimeric immunogens, expression vectors comprising the polynucleotides, and kits comprising the compositions are also provided.
REFERENCES:
patent: 5458878 (1995-10-01), Pastan et al.
patent: 5512658 (1996-04-01), Pastan et al.
patent: 5602095 (1997-02-01), Pastan et al.
patent: 5668255 (1997-09-01), Murphy
patent: 5696237 (1997-12-01), FitzGerald et al.
patent: 5747269 (1998-05-01), Rammensee et al.
patent: 5807832 (1998-09-01), Russell-Jones et al.
patent: 5824315 (1998-10-01), Nag
patent: 5863745 (1999-01-01), Fitzgerald et al.
patent: 5869608 (1999-02-01), Caldwell et al.
patent: 5917021 (1999-06-01), Lee
patent: 5922680 (1999-07-01), Fjellestad-Paulsen et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5965406 (1999-10-01), Murphy
patent: 5997856 (1999-12-01), Hora et al.
patent: 6007791 (1999-12-01), Coombes et al.
patent: 6022950 (2000-02-01), Murphy
patent: 6051405 (2000-04-01), FitzGerald et al.
patent: 6086918 (2000-07-01), Stern et al.
patent: 6133229 (2000-10-01), Gibson et al.
patent: 6174529 (2001-01-01), Michael et al.
patent: 6239116 (2001-05-01), Krieg et al.
patent: 6251392 (2001-06-01), Hein et al.
patent: 6255284 (2001-07-01), McGregor et al.
patent: 6391296 (2002-05-01), Okano et al.
patent: 6440419 (2002-08-01), Hein et al.
patent: 6488926 (2002-12-01), Khan et al.
patent: 6500641 (2002-12-01), Chen et al.
patent: 6525102 (2003-02-01), Chen et al.
patent: 6573237 (2003-06-01), Rinella, Jr.
patent: 6579854 (2003-06-01), Mitchell et al.
patent: 6613332 (2003-09-01), Michael et al.
patent: 6653292 (2003-11-01), Kreig et al.
patent: 6699678 (2004-03-01), Ohana
patent: 6716623 (2004-04-01), Chen et al.
patent: 6720146 (2004-04-01), Stolk et al.
patent: 6759241 (2004-07-01), Hone et al.
patent: 7314632 (2008-01-01), Fitzgerald
patent: 7611714 (2009-11-01), Mrsny
patent: 2004/0152649 (2004-08-01), Krieg
patent: 2009/0214582 (2009-08-01), Dean
patent: 2188638 (1987-10-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO 91/00360 (1991-01-01), None
patent: WO 91/18088 (1991-11-01), None
patent: WO 92/05793 (1992-04-01), None
patent: WO 92/08802 (1992-05-01), None
patent: WO 93/17715 (1993-09-01), None
patent: WO 94/02506 (1994-02-01), None
patent: WO 94/06827 (1994-03-01), None
patent: WO 94/25060 (1994-11-01), None
patent: WO 94/26900 (1994-11-01), None
patent: WO 96/16178 (1996-05-01), None
patent: WO 99/02712 (1999-01-01), None
patent: WO 99/02713 (1999-01-01), None
patent: WO 02/060935 (2002-08-01), None
patent: WO 2007027954 (2007-03-01), None
Grigera et al Journal of Virology, vol. 70, p. 8492-8501.
Allured, A.S. et al., 1986, “Structure of Exotoxin A of Pseudomonas Aeruginosa at 3.0 Angstrom Resolution,” Proc. Natl. Acad. Sci., vol. 83:1320-1324.
Amit et al., 1986, “Three-Dimensional Structure of an Antigen-Antibody Complex at 2.8 A Resolution,” Science, vol. 233:747-753.
Baehr et al., 1988, “Mapping Antigen Domains Expressed byChlamydia trachomatisMajor Outer Membrane Protein Genes,” Proc. Natl. Acad. Sci., USA, vol. 85:4000-4004.
Becerra et al., 2003, “CD8+ T-Cell Mediated Tumor Protection by Pseudomonas Exotoxin Fused to Ovalbumin in C57BL/6 Mice,” Surgery, vol. 133(4):404-410.
Bot et al., 1996, “DNA Immunization of Newborn Mice with a Plasmid-Expressing Nucleoprotein of Influenza Virus,” Viral Immunol., vol. 9(4):207-210.
Boyaka et al., 2003, “Therapeutic Manipulation of the Immune System: Enhancement of Innate and Adaptive Mucosal Immunity,” Current Pharmaceutical Design, vol. 9:1965-1972.
Buchner et al., 1992, “A Method for Increasing the Yield of Properly Folded Recombinant Fusion Proteins: Single-Chain Immunotoxins from Renaturation of Bacterial Inclusion Bodies,” Anal. Biochem., vol. 205:263-270.
Caldwell et al., 1981, “Purification and Partial Characterization of the Major Outer Membrane Protein ofChlamydia trachomatis,” Infection and Immunity, vol. 31:1161-1176.
Carlson et al., 1989, “Cloning and Characterization of aChlamydia trachomatisL3 DNA Fragment that Codes for an Antigenic Region of the Major Outer Membrane Protein and Specifically Hybridizes to the C- and C-Related—Complex Serovars,” Infection and Immunity, vol. 57(2):487-494.
Coombes et al., 2001, “Dendritic Cell Discoveries Provide New Insight into the Cellular Immunobiology of DNA Vaccines,” Immunology Letters 3, vol. 78:103-111.
Dean and Powers, 2001, “PersistentChlamydia trachomatisInfections Resist Apoptotic Stimuli,” Infection and Immunity, vol. 69(4):2442-2447.
Dean and Millman, 1997, “Molecular and Mutation Trends Analyses of omp1 Alleles for Serovar E ofChlamydia trachomatis,” J. Clin. Invest., vol. 99:475-483.
Figdor et al., 2003, “Molecular Characterization of Dendritic Cells Operating at the Interface of Innate of Acquired Immunity,” Pathol. Biol. (Paris)., vol. 51(2):61-63.
Fitzgerald et al., 1998, “Characterization of V3 Loop-Pseudomonas Exotoxin Chimeras,” J. Biol. Chem., vol. 273(16):9951-9958.
Germain et al., 1993, “The Biochemistry and Cell Biology of Antigen Processing and Presentation,” Annu. Rev. Immunol., vol. 11:403-450.
Hamilton and Malinowski, 1989, “Nucleoside Sequence of the Major Outer Membrane Protein Gene fromChlamydia trachomatisSerovar H,” Nucleic Acids Res. 17(20):8366.
Hayes et al., 1995, “Extent and Kinetics of Genetic Change in the omp1 Gene ofChlamydia trachomatisin Two Villages with Endemic Trachoma,” J. Infect. Dis., vol. 172:268-272.
Hayes et al., 1990, “The Major Outer-Membrane Proteins ofChlamydia trachomatisSerovars A and B: Intra-Serovar Amino Acid Changes do not Alter Specificities of Serovar- and C Subspecies-Reactive Antibody-Binding Domains,” J. Gen. Microbiol. 136(Pt 8):1559-1566.
Hertle et al., 2001, “Dual-Function Vaccine for Pseudomonas Seruginosa: Characterization of Chimeric Exotoxin A-Pilin Protein,” Infection and Immunity, vol. 69(11):6962-6969.
Huse et al., 1988, “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,” Science, vol. 246:1275-1281.
Ishibashi et al., 1993, “Hypercholesterolemia in Low Density Lipoprotein Receptor Knockout Mice and its Reversal by Adenovirus-Mediated Gene Delivery,” J. Clin. Invest., vol. 92:883-893.
Ito et al., 1990, “Variation in Virulence Among Oculogenital Serovars ofChlamydia trachomatisin Experimental Genital Tract Infection,” Infect. Immun., vol. 58(6):2021-2023.
Katz, 1998, “Antigen Presentation, Antigen-Presenting Cells and Antigen Processing,” Curr. Opin. Immunol., vol. 1(2):213-219.
Kay et al., 1994, “In Vivo Hepatic Gene Therapy: Complete Albeit Transient Correction of Factor IX Deficiency in Hemophilia B Dogs,” Proc. Natl. Acad. Sci. USA, vol. 91:2353-2357.
Kostelny et al., 1992, “Formation of a Bispecific Antibody by the Use of Leucine Zippers,” J. Immunol., vol. 148(5):1547-1553.
Kounnas et al., 1992, “The α2-Macroglobulin Receptor/Low Density Lipoprotein Receptor-Related Protein Binds and Internalizes Pseudomonas Exotoxin A,” J. Biol. Chem., vol. 267(18):12420-12423.
Lippolis et al., 2000, “Pseudomonas Exotoxin-Mediated Delivery of Exogenous Antigens to MHC Class I and Class II Processing Pathways,” Cell. Immunol., vol. 203:75-83.
Lukac et al., 1988, “Toxoid of Pseudomonas A
Dean Deborah
Mrsny Randall J.
Baskar Padma V
Bozicevic Field & Francis LLP
Chandra Shweta
Children's Hospital & Research Center at Oakland
Francis Carol L.
LandOfFree
Methods and compositions for immunizing against Chlamydia... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for immunizing against Chlamydia..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for immunizing against Chlamydia... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639383